Search Results
Nov 20, 2025, 09:00 ET Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
molecular diagnostic products at accessible prices. *The Co-Dx PCR platform (including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies
More news about: Co-Diagnostics
Nov 20, 2025, 07:30 ET Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
Exact Sciences' product lines feature advanced cancer screening and diagnostic solutions, including the market-leading Cologuard® and Oncotype DX® tests, and cutting-edge liquid biopsy tests for multi-cancer early detection and molecular residual disease testing Acquisition
More news about: Abbott
Nov 19, 2025, 08:39 ET Eventide Communications Announces NexLog DX-Series Recorders Meet FAA Modernization Requirements
interoperability requirements of FAA NextGen and NAS Voice System (NVS) programs, NexLog DX-Series systems are field-proven, standards-based recorders designed to replace legacy voice and screen recording systems. Eventide's NexLog DX-Series recorders support air traffic modernization objectives across the National
More news about: Eventide Communications LLC
Nov 18, 2025, 09:45 ET A First-of-Its-Kind, Formula-Free Guide to AI and Machine Learning for Decision Makers, by Corina J. Shtir, PhD
how these powerful tools can unlock and expand human creativity to improve our everyday lives."— Hakan Sakul, PhD, President, Precision Dx Strategies; Former Vice President and Head of Diagnostics, Pfizer "An essential tool for the non-expert executive…"—
More news about: Dexwell Inc.
Nov 18, 2025, 09:00 ET Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA
on the compact Co-Dx PCR Pro instrument. Using reverse-transcriptase PCR, the device provides decentralized upper respiratory infection test results at the point-of-care or near point-of-care. *The Co-Dx PCR platform (including
More news about: Co-Diagnostics
Nov 18, 2025, 05:40 ET Oncology Molecular Diagnostics Market to Reach US$ 6.46 Billion by 2033, Driven by Precision Oncology, and Accelerating Biomarker-Based Therapies - According to DataM Intelligence
high-throughput laboratory systems. QIAGEN maintains a significant foothold with its QIASymphony and QIAstat-Dx systems, along with expanding CDx collaborations. Roche continues to dominate the precision-diagnostics
More news about: DataM Intelligence 4 Market Research LLP
Nov 13, 2025, 23:05 ET transcosmos co-sponsors Baton no Yokoku Conference 2025
require attention. Through this conference, transcosmos will contribute to society by leveraging its expertise and technology as a Digital Transformation (DX) company. With the aim of creating a sustainable society that advances in partnership with local communities, transcosmos will
More news about: transcosmos inc.
Nov 13, 2025, 16:01 ET Co-Diagnostics Reports Third Quarter 2025 Financial Results
SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced
More news about: Co-Diagnostics
Nov 13, 2025, 06:13 ET MolecuLight to Exhibit and Showcase New Consensus on Fluorescence Imaging in Surgical Wound Management at IPAWS Summit 2025
company with a global footprint, dedicated to manufacturing and commercializing the MolecuLight i:X® and DX® wound imaging devices. Both FDA-cleared Class II point-of-care systems provide real-time detection of elevated bacterial burden and accurate digital
More news about: MolecuLight Corp.
Nov 12, 2025, 09:00 ET Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications
More news about: Co-Diagnostics
Nov 12, 2025, 08:34 ET Dr. Omar K. Danner Invests in Dream Exchange
"Dr. Danner's investment demonstrates the breadth of support we are building for Dream Exchange," said Dwain Kyles, Managing Member of DX Capital Partners. "When investors from diverse professional backgrounds recognize the market needs we are addressing, it reinforces our belief that we
More news about: Dream Exchange
Nov 12, 2025, 03:00 ET HS Hyosung Signs Joint Venture Agreement with Umicore for Next-Generation Anode Material Business
portfolio, expanding into high-potential sectors such as carbon fiber (used in aerospace, future mobility, defense, and energy), battery materials, and AI/DX business models. These additions complement its existing foundation in tire cord and advanced mobility materials, positioning
More news about: HS HYOSUNG
Nov 11, 2025, 23:05 ET transcosmos expands services for Chief Logistics Officers to help address Japan's 2024 problems in logistics and comply with two revised logistics laws
plans. To support businesses in addressing the 2024 problem and complying with the revised laws, transcosmos will offer trans-logiManager, a new logistics DX (digital transformation) solution that expands the features of its logistics cost optimization services launched in July 2024. The new solution first
More news about: transcosmos inc.
Nov 06, 2025, 10:00 ET Visit Regal on November 11 to Celebrate America's Veterans with Popcorn and Movies
Regal is focused on delivering the best moviegoing experience by providing our guests with the largest selection of premium large formats (including 4DX, IMAX, RPX, and ScreenX), the only unlimited subscription program, and enhanced food and beverage offerings to make every visit to the theatre a truly
More news about: Regal
Nov 06, 2025, 03:00 ET Fujifilm Selects IPfolio from Clarivate
President, General Manager, Intellectual Property Div. at FUJIFILM Holdings Corporation, said: "In introducing an IP management system suitable for the AI/DX era to transform our IP operations, we have placed great importance on a highly scalable data infrastructure and seamless integration with various internal
More news about: Clarivate Plc
Nov 06, 2025, 03:00 ET Fujifilm Selects IPfolio from Clarivate
President, General Manager, Intellectual Property Div. at FUJIFILM Holdings Corporation, said: "In introducing an IP management system suitable for the AI/DX era to transform our IP operations, we have placed great importance on a highly scalable data infrastructure and seamless integration with various internal
More news about: Clarivate Plc
Nov 06, 2025, 01:11 ET DEEPX榮獲兩項2026年CES創新獎；其DX-M1芯片為「最佳創新獎」得主Sixfab的ALPON X5提供動力支持
/美通社/ -- 全球人工智能(AI)半導體企業DEEPX（首席執行官：Lokwon Kim）宣布，該公司已斬獲兩項2026年國際消費電子展(CES)創新獎，此外，美國物聯網(IoT)與邊緣計算企業Sixfab憑借搭載DEEPX DX-M1芯片的AI網關ALPON X5，榮獲CES最高榮譽——最佳創新獎。這一裡程碑事件彰顯了DEEPX的解決方案如何進一步鞏固其作為全球「物理AI」標准的地位，同時強化其全球合作伙伴生態系統。
More news about: 迪普爱思
Nov 06, 2025, 00:16 ET DEEPX Wins Two CES 2026 Innovation Awards; Its DX-M1 Powers Best of Innovation Winner ALPON X5 by Sixfab
US-based IoT and edge computing company, received the Best of Innovation award — CES's highest honor — for its AI gateway ALPON X5 powered by DEEPX's DX-M1. This milestone demonstrates how DEEPX's solutions are further solidifying its position as the global standard for 'Physical AI' while strengthening
More news about: DEEPX
Nov 05, 2025, 23:34 ET DEEPX Wins Two CES 2026 Innovation Awards; Its DX-M1 Powers Best of Innovation Winner ALPON X5 by Sixfab
US-based IoT and edge computing company, received the Best of Innovation award — CES's highest honor — for its AI gateway ALPON X5 powered by DEEPX's DX-M1. This milestone demonstrates how DEEPX's solutions are further solidifying its position as the global standard for 'Physical AI' while strengthening
More news about: DEEPX
Nov 05, 2025, 09:01 ET Trader Interactive Launches Digital Platform Enabling Multi-Lender Finance Integrations for RV and Powersports Dealers
credit application delivery through 700Credit, AppOne, Dealertrack, and Route One, and is bridged with Lightspeed, DX1 and additional industry leading DMS and CRM systems. Dealers can learn more or activate the new Dealer Financing product
More news about: Trader Interactive
Nov 05, 2025, 09:00 ET Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
LAKE CITY, Nov. 5, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular diagnostic tests, today announced that it has engaged Maxim
More news about: Co-Diagnostics
Nov 03, 2025, 09:00 ET Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
with the Company's HIPAA-compliant Co-Dx cloud platform and internal databases to form the foundation of Co-Dx Primer Ai. *The Co-Dx PCR platform (including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and all associated
More news about: Co-Diagnostics
Nov 03, 2025, 01:00 ET KOSA and MegazoneCloud to Lead Korea's AI-SW Delegation at ADIPEC 2025
sectors. Located in Hall 17 of the Abu Dhabi National Exhibition Centre (ADNEC), the KOREA AI Pavilion will highlight the slogan "Smart DX Powered by AI", emphasizing the role of Korean AI technology in driving digital transformation within the global energy industry. Participating companies
More news about: The Korea Artificial Intelligence & Software Industry Association
Oct 31, 2025, 09:00 ET Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications
More news about: Co-Diagnostics
Oct 31, 2025, 08:00 ET AI Semiconductor Innovator DEEPX Recognized by NYSE and WEF
efficiency compared with GPUs and roughly 90 percent lower system cost. Mass-production deployments are already underway at Hyundai Motor Robotics Lab, POSCO DX, Baidu, LGUplus, and other companies. DEEPX's growth is inspired by two strands of industrial DNA. Firstly, Arm's philosophy: Just
More news about: DEEPX